AJOVista’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History

AJOVista’s Portfolio THRX Stock Details THRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-9,520	Closed	-$38.6K	–	454
2023 Q4	$38.6K	Buy	+9,520	New	+$29K	0.05%	320

AJOVista's THRX Position: Q1 2024 in Review

AJOVista sold out of Theseus Pharmaceuticals, Inc. Common Stock (THRX) in Q1 2024, closing a stake of 9,520 shares — an estimated $38.6K sold.

AJOVista first reported a position in THRX in Q4 2023 and held it in 1 quarter. The position peaked at $38.6K in Q4 2023. 1 fund tracked by Wall St. Rank holds THRX as of Q1 2024.

AJOVista reported no remaining Theseus Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
AJOVista sold 9,520 Theseus Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $38.6K.
AJOVista first reported a position in Theseus Pharmaceuticals, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
AJOVista's Theseus Pharmaceuticals, Inc. Common Stock position peaked at $38.6K in Q4 2023.
1 fund tracked by Wall St. Rank held Theseus Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on AJOVista's 13F filing for Q1 2024, filed 10 May 2024.